Bristol-Myers Squibb Co (NYSE: BMY)

DRUGS - Drug Manufacturers - Major
Sector: Health Care

Stock price data as of 12/06/2024

Closing price: 59.38

Support price level:	$55.78
Resistance price level:	N/A
Relative strength index (14-day RSI)	71.5
Beta	0.07

BMY is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
The price of this low-beta stock is expected to increase by 0.07% for every 1% increase in the S&P-500.
Volatility is forecast to fall over the next month.
With RSI > 70, BMY is overbought. Odds slightly favor a short-term price reversal.
Price broke above prior resistance level - a short-term bullish signal.

Low	High	Price as % of Range
$39.66	$59.94	97.7%

200 day	50 day	20 day	10 day
$48.95	$55.31	$58.37	$59.01

(Annualized standard deviation)

Historical (5 year)	Last month	Current estimate	Next month forecast
23.5%	27.5%	23.3%	23.0%

There is an estimated 5% probability that the stock price of Bristol-Myers Squibb Co will fall by more than: